Obesity Diabetes Acid Reflux Anxiety And Low Iron Nutrition Plan

πŸ”₯+ Obesity Diabetes Acid Reflux Anxiety And Low Iron Nutrition Plan 01 Jun 2020 analysis, disease state, drinking and driving, DUI challenges, gastric reflux. The use of breath alcohol testing has long traditions in clinical medicine, alcohol ...

Obesity Diabetes Acid Reflux Anxiety And Low Iron Nutrition Plan {ICD-9-CM V12.79 is a billable medical code that can be used to indicate a ... History of gastrointestinal bleed; History of heartburn; History of inflammation of ...|ICD-9. Code. Diagnoses. ICD-10. Code. 009.1. Infectious gastroenteritis and ... 78900. Unspecified abdominal pain. R10.9. V10.05. Personal history of other ...|Z87.19 is a billable/specific ICD-10-CM code that can be used to indicate a ... of gastroesophageal reflux disease; History of gastroesophageal reflux disease ...|ICD-9 Code ICD-9 Description ... K21.9 Gastroesophageal reflux disease without esophagitis ... D50.9 Iron deficiency anemia, unspecified ... Hx Colon Polyp.|Z87.19 is a billable code used to specify a medical diagnosis of personal history ... History of gastroesophageal reflux disease; History of gastrointestinal bleed ...|No diagnosis code for GERD (530.81 or 530.11); No history of relevant medications (see Table1); No exclusionary ICD 9 codes (see Table3). Covariates: Age ...|It covers ICD codes 520 to 579. The full chapter can be found on pages 301 to 328 of Volume 1, which contains all (sub)categories of the ICD-9. Volume 2 ...|V18.9 Family History, Genetic Disease Carrier. V67.51 Follow-Up High-Risk Medication,. Completed Tx. V26.33 Genetic Counseling. V15.84 History of Asbestos ...|Old ICD-9 Code. Health Condition. Recommended ICD 10. 315.31 ... Anaphylaxis, Personal history of/Epipen. Z87.892. 285.90. Anemia. D64.9. 307.10 ... 530.81. GERD. K21.9. 523.10. Gingivitis. K05.1. 583.00. Glomerulonephritis. N05.9.|Effective October 1, 2015, ICD-9-CM codes provided in this version are for historical ... Family history of malignant neoplasm, trachea, bronchus, and lung. V16.2.|I. Infectious & Parasitic Diseases. 127.0 Ascariasis. 790.7 Bacteremia (not septicemia). 052.9 Chickenpox, NOS. 133.8 Chiggers. 078.5 CMV disease.|The ICD-10-CM terms provide new detail as compared to the ICD-9-CM code ... Medical history significant for GERD, peptic ulcer, pre-eclampsia with last ...|ICD-9 Diagnosis Codes. Source: Centers for Medicare ... 7871 Heartburn. 78720 Dysphagia NOS ... V1009 Hx of GI malignancy NEC. V1011 Hx-bronchogenic ...|Research Hospitalization Volume, DRGs, Quality Outcomes, Top Hospitals & Physicians for K219 - Gastro-esophageal reflux disease without esophagitis - ICD ...|relationship between multiple GERD symptoms and the motivation to visit a MC in a large- ... addressed the following: 1) history of visiting a MC, 2) present symptoms, and 3) most ... Two ICD-9 codes used in healthcare billing for GI bleeding.|swallowing disorders. This document is not a comprehensive list and a number of codes are included for information purposes only. Entries with ...|Z88.9. Adverse Effects Other allergy. T78.49Xx. 7th digit for this code: A - Initial Visit D - Subsequent Visit or S for Sequela ... (Z77.22) history of tobacco use Z87.891) occupational to environmental ... GERD/Gastroesophageal Reflux Disease.|The condition is classified to ICD-9-CM subcategory 787.2, with a fifth-digit ... The specific code assignment depends on where the dysphagia occurs in the swallowing process. ... gastroesophageal reflux disease (530.81);.|diagnoses of GERD (see ICD9 and ICD10 code lists below) in the primary ... medical encounter that includes a defining diagnosis of GERD.|Medical Report 7.3 ABC MEDICAL CENTER HISTORY AND PHYSICAL ... He denies any nausea, vomiting, heartburn, diarrhea problems, constipation, ...|Workbook with ICD-9 codes - Coronary Artery Disease (CAD). Trigger Codes CAD. Code. Type. ICD-9 Group Name. Code Value(s). DX. Unstable angina. 4111, 41181, 41189, 4130, 4131, ... CV - family hx ... drugs for peptic ulcer and gerd.|Diagnosis. Code. ICD-9 Diagnosis. Description. ICD-10. Diagnosis. Code. ICD-10 Diagnosis Description. 244.9. Unspecified acquired hypothyroidism. E03.9 ... Heartburn. R12. Heartburn. 787.20. Dysphagia, unspecified. R13.0. Aphagia. R13.10 ... Personal history of adult physical and sexual abuse. V15.42. Personal ...|ICD9 Description. 764 'LIGHT-FOR-DATES' INFANT NO FETAL MALNUTRITION. 764.01 'LIGHT-FOR-DATES' INFANT NO FETAL MALNUTRITION <50.|... Genetic Parental family history 3,920 1.5 1.2-1.7 Mohammed, 2005 Aging Increasing age GERD (ICD-9 code) 1.1 1.0-1.1 Kotzan, 2001 Structural 163,085 4.2 ...|neoplasm of breast], and V10.3 [Personal history of malignant neoplasm of breast], were ... then mapping the converted ICD-9 codes to phecodes. ... without esophagitis. 530.11. GERD. 23,645. J06.9. Upper respiratory.|Inclusion or exclusion of a procedure, diagnosis or device code(s) does not ... GERD is usually diagnosed by clinical history and is typically treated initially with ...|A list of the most commonly used ICD-9 codes in Physical Medicine & Rehabilitation and Pain Management clinics. ICD-10 codes will be slowly added over time. ... in Pain Medicine · The History of Corticosteroids (Glucocorticoids) · Adverse Effects ... Gastroesophageal reflux (GERD): 530.81; Testosterone deficiency: 257.2 ...|E11.21 DM1 with Chronic Kidney Disease (Code Also CKD N18. -). E10.22 ... J32.9. ANEMIA. ICD-10 Hypertensive Heart & CKD w/o Heart Failure and CKD 5/ESRD 113.11 COPD with Acute Bronchitis ... ICD-10 DIGESTIVE SYSTEM. ICD-10. For CVA or TIA history without residual deficits,. Esophageal reflux (GERD).|Write Dx: 281.1. ICD.9.CM code on Rx. Transmit 281.1 in diagnosis field. Yes. Yes. Yes ... History of gastroduodenal ulcer(s) or GI bleeding ... GERD (530.81).|C. Accurate reporting of ICD‐10‐CM diagnosis codes. For accurate ... I42.9. E87.70. Cardiac/Circ. Status Codes, Hx & Screening. R01.1. Z95.810 ... Dysuria. GERD. Constipation. UTI. Diarrhea. 85th to < 95th percentile for age.|Translate the following lay terms into medical \g I ICD-9 code – 789.0. Age: toddler to ... REFLUX DISEASE (GERD). ICD-9 code – 530.11 ... Use history and physical to evaluate for triggers,. GERD, or neurologic ...

Drugs Treat Gerd
World J Gastrointest Endosc. 2010 Dec 16; 2(12): 388–396.
Published online 2010 Dec 16. doi:Β 10.4253/wjge.v2.i12.388
PMCID: PMC3010469
PMID: 21191512
Maxwell M Chait, Hartsdale Medical Group, Hartsdale, NY 10530, United States
Author contribution: Chait MM contributed solely to this paper.

Correspondence to: Maxwell M Chait, MD FACP, FACG, AGAF, FASGE, 180 East Hartsdale Avenue, Hartsdale, NY 10530, United States. [email protected]

Telephone: +1-914-7252010 Fax: +1-914-7256488

Received 2010 Oct 28; Revised 2010 Nov 29; Accepted 2010 Dec 6.
Copyright ©2010 Baishideng Publishing Group Co., Limited. All rights reserved.
This article has been cited by other articles in PMC.

Abstract

Gastroesophageal reflux disease (GERD) is the most common upper gastrointestinal disorder seen in the elderly. The worldwide incidence of GERD is increasing as the incidence of Helicobacter pylori is decreasing. Although elderly patients with GERD have fewer symptoms, their disease is more often severe. They have more esophageal and extraesophageal complications that may be potentially life threatening. Esophageal complications include erosive esophagitis, esophageal stricture, Barrett’s esophagus and adenocarcinoma of the esophagus. Extraesophageal complications include atypical chest pain that can simulate angina pectoris; ear, nose, and throat manifestations such as globus sensation, laryngitis, and dental problems; pulmonary problems such as chronic cough, asthma, and pulmonary aspiration. A more aggressive approach may be warranted in the elderly patient, because of the higher incidence of severe complications. Although the evaluation and management of GERD are generally the same in elderly patients as for all adults, there are specific issues of causation, evaluation and treatment that must be considered when dealing with the elderly.

Keywords: Gastroesophageal reflux disease, Older patient, Elderly

INTRODUCTION

Gastroesophageal reflux disease (GERD) is the most common upper gastrointestinal disorder encountered in the elderly patient. It is highly prevalent worldwide with a prevalence of 10%-20% in the western world[1-4]. It is estimated that GERD affects 18.6 million people in the United States[5,6]. The prevalence of weekly symptoms has increased to an annual rate of approximately 5% in North America[4]. In the US adult population, 10%-20% of people have symptoms at least once weekly and 15%-40% of people have symptoms at least once monthly[4]. Among adult patients with GERD who seek medical care, up to 20% have serious complications[7]. There has been an increasing incidence of GERD and its complications, including Barrett’s esophagus and adenocarcinoma of the esophagus, throughout the world[8-9]. No causal relationship has been demonstrated between Helicobacter pylori (H. Pylori) infection and gastroesophageal reflux disease. In fact, there is an inverse relationship of the prevalence of GERD to that of H. Pylori infection[10-11].

GERD has direct impact on quality of life, especially in the elderly. GERD patients reported a lower quality of life than unaffected individuals, especially in those with nighttime GERD[12]. In one study, 78% of GERD patients reported nocturnal symptoms and 63% of those patients reported that sleep was negatively affected[13].

GERD has a significant economic impact. In the US direct costs of medical consultations, testing and treatment total 9.3 billion dollars. In addition, indirect costs in the US of absenteeism and interference with job performance, which is termed presenteeism, total 75 billion dollars[14-15].

Although there is a tendency to reduced symptom frequency of the usual complaints of heartburn and acid regurgitation in older patients, the frequency of GERD complications, such as erosive esophagitis, esophageal stricture, Barrett’s esophagus, and esophageal cancer is significantly higher[6]. For example, Collen et al found an increase of esophagitis and Barrett’s esophagus in patients over 60 years of age compared to those younger, 81% versus 47%[16]. Huang et al[17] found more severe gastroesophageal reflux and esophageal lesions in elderly patients, as compared to younger patients. Therefore, elderly patients with GERD are at greater risk than younger patients for developing serious complications of GERD.

PATHOGENESIS

GERD is defined as symptoms or mucosal damage produced by the abnormal reflux of gastric contents into the esophagus[18]. A newer definition has been adopted which states that GERD is a condition that develops when reflux of gastric contents causes troublesome symptoms and/or complications[19]. The abnormalities that appear to play a pathogenic role in GERD tend to be more severe in the elderly patient and lead to the increased rate of GERD complications.

Injury to the esophagus is due to reflux of gastric acid and pepsin. However, duodenogastric reflux of bile may also cause esophageal injury[20]. The pathogenic abnormalities causing GERD include a defective antireflux barrier, abnormal esophageal clearance, reduced salivary production, altered esophageal mucosal resistance, and delayed gastric emptying.

The lower esophageal sphincter (LES) is the antireflux barrier[6] GERD most often occurs as a result of transient LES relaxations (tLESRs), where the drop in LES pressure is not accompanied by swallowing. The tLESRs promote acid reflux and the constellation of GERD problems. Incompetence of the LES was shown by Huang et al[17] to be more prevalent in the elderly. Furthermore, multiple medications more frequently taken by the elderly for co-morbid illnesses, such as hypertension, cardiovascular disease, and pulmonary disease and depression are well known to decrease LES pressure. These include nitrates, calcium channel blockers, benzodiazepines, anticholinergic agents, and antidepressants. The frequency of hiatal hernia and the loss of the diaphragmatic “pinch” which impairs the function of the LES and the clearance of refluxed acid from the distal esophagus also appear to increase with age[21].

Esophageal acid clearance is impaired in the elderly due to disturbances of esophageal motility and saliva production. In elderly patients, there is a significant decrease in the amplitude of peristaltic contraction and an increase in the frequency of nonpropulsive and repetitive contractions compared to younger individuals, often referred to as presbyesophagus[21]. Salivary production slightly decreases with age and is associated with a significantly decreased salivary bicarbonate response to acid perfusion of the esophagus[22]. Many of the medications noted above taken by elderly patients adversely affect esophageal motility as well as the LES. Many diseases that can negatively affect esophageal motility appear with greater frequency with advancing age, such as Parkinson’s disease, cerebrovascular disease, cardiovascular disease, pulmonary disease and diabetes mellitus.

Gastric dysmotility with delayed gastric emptying and duodenogastric reflux of bile plays a significant role in GERD pathogenesis in elderly patients and is an important consideration in elderly patients that poorly respond to acid reducing medication. Delayed gastric emptying and duodenogastric reflux may be a significant cause of non-erosive reflux disease (NERD) and non-ulcer dyspepsia (NUD). Many of the medications taken by elderly patients that adversely affect esophageal motility as well as the LES also negatively affect gastric dysmotility with delayed gastric emptying and duodenogastric reflux[20].

Direct esophageal injury occurs more frequently in the elderly, because of medications given for co-morbid illnesses such as cardiovascular diseases, cerebrovascular disease, arthritis and osteoporosis that can directly injure the esophageal mucosa. These medications include nonsteroidal anti-inflammatory drugs (NSAIDs), potassium tablets, iron supplements and bisphosphonates.

Reduced pain perception can increase the rate of GERD complications in the elderly, because acid injury can occur without the usual warning symptom significant heartburn and acid reflux symptoms[7]. Gastric acid secretion per se does not decrease with age alone. However, there is a decrease in esophageal pain perception with advancing age[21]. In addition, atrophic gastritis is more common in the elderly[23]. It may be associated with anti-parietal cell antibodies and pernicious anemia. H. pylori is also associated with decreased acid production and reduced acid reflux symptoms[10-11].

Lifestyle factors can be associated with increased gastroesophageal reflux and more complications of GERD[7]. Tobacco smoking, caffeine, alcohol and fatty foods adversely affect GERD. Obesity, sedentary lifestyle and nocturnal gastroesophageal reflux are important mechanisms that are associated with more severe esophageal and extraesophageal complications of GERD in the elderly[12-13]. Obesity is a significant problem which increases acid reflux and thus increases GERD and its complications[24]. Nocturnal effects on GERD are reported by up to 78% of patients, with 75% of patients reporting that it negatively affects their ability to sleep[12]. Nocturnal gastroesophageal reflux and the recumbent, supine position remove the protective effect of gravity in GERD in the elderly patient[26-27]. Nocturnal GERD allows for more gastroesophageal reflux and further increases esophageal injury and GERD complications, especially in elderly patients who often spend more time in bed due to comorbid illness, such as dementia, Parkinson’s disease, cerebrovascular disease, cardiovascular disease, pulmonary disease and diabetes mellitus.

The worldwide variation in incidence of GERD may be inversely related to the prevalence of H Pylori infection[11]. Studies have found a negative association between the prevalence of H. Pylori infection and GERD that is more marked with the more virulent CagA strains[27]. Additionally, they have shown a negative association of H. Pylori status and the complications of GERD including Barrett’s esophagus and esophageal adenocarcinoma[27]. A study by Labins revealed a possible protective effect of H. Pylori infection in the subgroup analysis of patients with severe esophagitis[10]. In a study from China, a stepwise relationship was found between increasing grade of esophagitis and decreasing prevalence of H. Pylori[28]. In a Swedish study, H. Pylori was found to be associated with a significantly decreased risk of adenocarcinoma of the esophagus[29]. A subgroup analysis showed that the negative association was only apparent for the CagA positive strains of H. Pylori.

CLINICAL PRESENTATION

The most common symptoms of GERD the 1 last update 01 Jun 2020 are heartburn and acid regurgitation[30]. Other common symptoms include water brash, belching, and nausea. Important symptoms that herald more severe disease include dysphagia, odynophagia, anemia, unexplained weight loss, and gastrointestinal bleeding[31].The most common symptoms of GERD are heartburn and acid regurgitation[30]. Other common symptoms include water brash, belching, and nausea. Important symptoms that herald more severe disease include dysphagia, odynophagia, anemia, unexplained weight loss, and gastrointestinal bleeding[31].

Heartburn is characterized by epigastric and retrosternal burning pain that may radiate to the neck, throat, and back. It often occurs after large meals, exercise, or reclining. Remarkably, the frequency of severe heartburn seems to decline with age, possibly due to a decrease in esophageal pain perception and atrophic gastritis. Dysphagia, difficulty in swallowing, is an important symptom that has been reported in 7% to 22% of the general population. In the frail elderly nursing home patient dysphagia is reported in 40% to 50% of patients[32]. When it occurs in response to both solids and liquids or more to liquids than solids, it is may be related to esophageal dysmotility due to disease states more common in the elderly, such as Parkinson’s disease, cerebrovascular disease, dementia and diabetes. However, when it occurs in response to solids more than liquids, it may be structural in nature and due to severe esophagitis, esophageal stricture or esophageal cancer

Other important symptoms that signify more severe disease are odynophagia, anemia, unexplained weight loss, and gastrointestinal bleeding. These may signal problems such as severe esophagitis, esophageal ulcer, esophageal stricture, Barrett’s esophagus or esophageal cancer.

Extrasesophageal symptoms occur more commonly in the elderly. They include atypical chest pain that can simulate angina pectoris; ear, nose, and throat (ENT) manifestations such as globus sensation, laryngitis, and dental problems; pulmonary problems such as chronic cough, asthma, and pulmonary aspiration and sleep apnea[33].

COMPLICATIONS

Complications of GERD that are potentially severe are more common in the elderly. Among patients with GERD seeking medical care in the United States, 20% have complications[7]. Complications may be esophageal or the 1 last update 01 Jun 2020 extraesophageal in nature and may vary from mild esophagitis to major life threatening problems such as recurrent pulmonary aspiration, Barrett’s esophagus, and esophageal cancer[7,9] (Table (Table11).Complications of GERD that are potentially severe are more common in the elderly. Among patients with GERD seeking medical care in the United States, 20% have complications[7]. Complications may be esophageal or extraesophageal in nature and may vary from mild esophagitis to major life threatening problems such as recurrent pulmonary aspiration, Barrett’s esophagus, and esophageal cancer[7,9] (Table (Table11).

Table 1

Complications of gastroesophageal reflux disease

Esophageal
Erosive esophagitis
Esophageal stricture
Barrett’s esophagus
Esophageal adenocarcinoma
Extraesophageal
Atypical noncardiac chest pain
ENT complications
Globus sensation
Pharyngitis
Sinusitis
Otits media
Dental erosions
Hoarseness
Laryngitis
Vocal cord granulomas
Subglottic stenosis
Laryngeal cancer
Pulmonary complications
Chronic cough
Asthma
Chronic bronchitis
Pulmonary fibrosis
Aspiration pneumonia
Sleep apnea

ENT: ear, nose, and throat.

Esophageal complications

As in younger patients, the most common complication of GERD in the elderly is esophagitis. This may progress from non-erosive esophagitis (NERD) to severe esophageal erosions, ulcerations and hemorrhage[33]. Esophageal stricture occurs in the 1 last update 01 Jun 2020 up to 10% of patients who have reflux esophagitis, especially in elderly men. Esophageal strictures are often associated with the use of NSAIDs. Treatment with esophageal dilatation and aggressive antireflux therapy is usually effective.As in younger patients, the most common complication of GERD in the elderly is esophagitis. This may progress from non-erosive esophagitis (NERD) to severe esophageal erosions, ulcerations and hemorrhage[33]. Esophageal stricture occurs in up to 10% of patients who have reflux esophagitis, especially in elderly men. Esophageal strictures are often associated with the use of NSAIDs. Treatment with esophageal dilatation and aggressive antireflux therapy is usually effective.

An important and increasingly common esophageal complication is Barrett’s esophagus, in which columnar epithelium replaces squamous epithelium in the distal esophagus[34]. Barrett’s esophagus is a premalignant condition highly associated with the development of adenocarcinoma of the esophagus and the gastric cardia. It is found in approximately 10%-15% of patients with GERD symptoms who undergo endoscopic examinations. It is more common in elderly Caucasian men over the age of 60[9]. Although its pathogenesis remains uncertain, acid reflux appears to injure the squamous epithelium and promote epithelial repair by columnar metaplasia of the esophageal mucosa. Because of the frequency and importance of Barrett’s esophagus, upper GI endoscopy should be considered in all elderly patients with recurrent reflux symptoms. Patients with Barrett’s esophagus must be evaluated with multiple biopsies to look for the presence of dysplasia, which is the precursor of invasive cancer. Continued endoscopic surveillance and aggressive measures, especially in high-grade dysplasia, are warranted to prevent adenocarcinoma of the esophagus. These measures include endoscopic ablative techniques such as endoscopic mucosal resection, electrocautery fulguration, laser photoablation, photodynamic therapy. Surgical esophagectomy in good operative risk patients with severe dysplasia is warranted[9].

Adenocarcinoma of the esophagus is among the fastest growing carcinomas by incidence in the United States where it has become the most common form of esophageal cancer[9]. The the 1 last update 01 Jun 2020 incidence of adenocarcinoma in patients with Barrett’s esophagus is approximately 1% per year. Patients with esophageal cancer typically present in the seventh or eighth decade of life with weight loss and dysphagia. Although the overall survival rate of patients with adenocarcinoma of the esophagus is less than 10%, those with early stage cancer identified in surveillance programs usually have a higher survival rate[35].Adenocarcinoma of the esophagus is among the fastest growing carcinomas by incidence in the United States where it has become the most common form of esophageal cancer[9]. The incidence of adenocarcinoma in patients with Barrett’s esophagus is approximately 1% per year. Patients with esophageal cancer typically present in the seventh or eighth decade of life with weight loss and dysphagia. Although the overall survival rate of patients with adenocarcinoma of the esophagus is less than 10%, those with early stage cancer identified in surveillance programs usually have a higher survival rate[35].

Extraesophageal complications

Extraesophageal complications of GERD are more common in the elderly[33]. These include atypical noncardiac chest pain; ear, nose, and throat (ENT) manifestations, such as globus sensation, laryngitis, otitis media, sinusitis, pharyngitis, hoarseness, vocal cord granulomas, subglottal stenosis, laryngeal cancer, dental erosions; pulmonary problems, such as asthma, chronic cough, chronic bronchitis, pulmonary fibrosis, aspiration pneumonia and sleep apnea.

Atypical noncardiac chest pain has been related to GERD in up to 60% of cases. In 50% of cases symptoms are related directly to reflux injury and in 10% symptoms are related to esophageal dysmotility. Atypical noncardiac chest pain due to GERD may often be indistinguishable from angina pectoris[36]. Therefore, a cardiac evaluation is indicated in these elderly patients before ascribing symptoms to GERD alone.

Ear, nose, and throat (ENT) complications of GERD are frequent in the elderly with laryngitis being the most common. In up to 10% of patients with hoarseness, acid peptic injury from reflux is the cause. Acid injury can also cause globus sensation, otitis media, sinusitis, pharyngitis, hoarseness, dental erosions, vocal cord granulomas, subglottal stenosis and laryngeal cancer. Prolonged antireflux therapy may be necessary and is often effective in these patients. However, prompt relapses occur when therapy is discontinued[37].

Pulmonary complications of GERD are common in the elderly. Conditions include asthma, chronic cough, chronic bronchitis, pulmonary fibrosis, aspiration pneumonia and sleep apnea are all seen more frequently in the elderly. In up to 21% of patients with chronic cough, GERD is the cause[38]. Remarkably, chronic cough can be the only symptom of GERD is some patients. The mechanism for the development of pulmonary complications is not only pulmonary aspiration of refluxed material but also involves a neurally mediated reflex bronchoconstriction due to esophageal irritation by acid[38]. As with for 1 last update 01 Jun 2020 ENT manifestations, antireflux therapy is often helpful with a prompt recurrence occurring upon discontinuation of therapy.Pulmonary complications of GERD are common in the elderly. Conditions include asthma, chronic cough, chronic bronchitis, pulmonary fibrosis, aspiration pneumonia and sleep apnea are all seen more frequently in the elderly. In up to 21% of patients with chronic cough, GERD is the cause[38]. Remarkably, chronic cough can be the only symptom of GERD is some patients. The mechanism for the development of pulmonary complications is not only pulmonary aspiration of refluxed material but also involves a neurally mediated reflex bronchoconstriction due to esophageal irritation by acid[38]. As with ENT manifestations, antireflux therapy is often helpful with a prompt recurrence occurring upon discontinuation of therapy.

EVALUATION

Diagnostic testing in older patients is essentially the same as for younger patients with GERD[39]. However, because of the higher incidence of complications in the elderly that may be severe and life threatening, an aggressive approach with prompt evaluation is warranted[7]. Barium swallow upper GI series and upper GI endoscopy are used to evaluate dysphagia and mucosal injury. Endoscopy is superior to the barium swallow exam, but must be used with caution in the elderly frail patient. Capsule endoscopy is evolving as a modality to evaluate the upper GI tract. It is less invasive than routine upper GI endoscopy and may be an alternative in the elderly patient. In patients with atypical symptoms or when quantification of reflux is required, ambulatory pH monitoring is helpful, but may be difficult to perform in the elderly patient. Wireless probes may improve compliance[40]. Multichannel intraluminal impedance measurement with a pH sensor allows the detection of pH episodes irrespective of their pH values (acid and nonacid reflux). This is useful in the postprandial period, in patients with persistent symptoms while on therapy and in those patients with atypical symptoms[41]. Esophageal manometry is often used in patients with markedly atypical symptoms, for locating the LES for pH testing, and in those for whom surgery is contemplated. However, it is not useful for the evaluation of GERD in the majority of patients.

The proton pump for 1 last update 01 Jun 2020 inhibitor (PPI) test has become a useful noninvasive test in elderly GERD patients for the evaluation atypical chest pain. Patients are given a course of high dose PPI agent, such as omeprazole 60 mg per day for 7 d, and observed for improvement in their clinical response[42]. However, this does not supplant the use of endoscopy in patients with significant symptoms, such as odynophagia and dysphagia.The proton pump inhibitor (PPI) test has become a useful noninvasive test in elderly GERD patients for the evaluation atypical chest pain. Patients are given a course of high dose PPI agent, such as omeprazole 60 mg per day for 7 d, and observed for improvement in their clinical response[42]. However, this does not supplant the use of endoscopy in patients with significant symptoms, such as odynophagia and dysphagia.

Diagnostic testing should be performed in patients in whom the diagnosis remains uncertain; in patients with atypical symptoms such as chest pain, ENT problems, or pulmonary complications; in patients with significant symptoms that are often associated with complications such as dysphagia, odynophagia, unexplained weight loss, GI hemorrhage, and anemia; in patients who have an inadequate response to therapy, whether medical or surgical; in patients with recurrent symptoms; and in patients prior to consideration of antireflux surgery[43].

There are important considerations relating to diagnostic and treatment methods in elderly patients[44]. In cognitively impaired patients, a Mini-Mental State Examination may be indicated. Informed consent to procedures may be difficult to obtain in patients who suffer from cognitive dysfunction. With the exception of a true life-threatening emergency, every attempt should be made to obtain consent for testing procedures from the patient, if competent, or the surrogate. In cases where a guardian cannot be reached, administrative consent should be obtained. Timing of tests and type of intervention should be tailored, especially for the frail elderly patient, depending upon functional status, its impact on outcome, and the available diagnostic strategies. However, intervention should not be withheld because of age alone.

Older patients are more likely to have pacemakers with or without defibrillators. Recommendations for management of patients who require endoscopy and have pacemakers and internal defibrillators are not well defined. Cardiology consultation may often be indicated. If required, alternative means of tissue removal, destruction, or hemostasis should be considered to simplify management of patients. For example, to control hemorrhage in the bleeding patient with a defibrillator one may need to use such methods as hemo-clips, ligation devices, and injection of epinephrine and sclerosing agents. The general principle of geriatric pharmacology of starting with low doses of medication and slowly advancing to larger doses is an important dictum in conscious sedation of the elderly patient during endoscopy. Initial dosages should be lower and titration should be more gradual[44]. Deeper sedation that requires an anesthesiologist may be warranted in difficult cases.

In contrast to younger patients, endoscopy should be considered as the initial diagnostic test in elderly patients with heartburn, regardless of the severity or duration of complaints. This aggressive approach is warranted because of the higher incidence of cumulative acid injury over time and the higher incidence of complications of Barrett’s esophagus and esophageal cancer in the elderly[16].

TREATMENT

Obesity Diabetes Acid Reflux Anxiety And Low Iron Nutrition Plan Diet For (⭐️ How To) | Obesity Diabetes Acid Reflux Anxiety And Low Iron Nutrition Plan Herbal Remedieshow to Obesity Diabetes Acid Reflux Anxiety And Low Iron Nutrition Plan for Treatment of GERD in the elderly patient is essentially the same as in all adults with GERD[33]. However, a more aggressive approach to treatment is necessary in the elderly patient, because of the higher incidence of complications[16]. This aggressive approach must be balanced with the constraints of dealing with an older often frailer patient with comorbidities. The treatment goals, as in all patients with GERD, are elimination of symptoms, healing of esophagitis, managing or preventing complications, and maintaining remission[43]. The vast majority of patients can be treated successfully with the noninvasive methods of lifestyle modification and medication[43] (Table the 1 last update 01 Jun 2020 (Table2(Table22).

Table 2

Noninvasive treatment of gastroesophageal reflux disease1

Lifestyle modification
Elevation of head of bed
Avoid eating within 3 h of bedtime
Avoid tobacco, alcohol, caffeine, fatty food, peppermint
Avoid harmful medications if possible, such as NSAIDs, beta blockers
Calcium-channel blockers, theophylline, potassium tablets, bisphosphonate
Medications
Antacids
Motility agents:
Metoclopramide, erythromycin, bethanechol, cisapride, GABA B-receptor agonists
H2 receptor antagonists:
Cimetidine, famotidine, nizatidine, ranitidine
PPI agents1:
Esomeprazole, lansoprazole, omeprazole, pantoprazole, rabeprazole, dexlansoprazole

GABA: Gamma-aminobutyric acid B-receptor agonist; NSAIDS: nonsteroidal anti-inflammatory drugs; H2: histamine2; PPI: proton pump inhibitor;

1Most often successful.

Although lifestyle modification remains a cornerstone of initial therapy in GERD, it may not be sufficient to control symptoms in the majority of patients, especially in those with complications. However, patients should try to loose weight, be more active, elevate the head of their bed before going to sleep, avoid eating within three hours of bedtime, stop tobacco smoking, decrease dietary fat and volume of meals and avoid dietary irritants such as alcohol, peppermint, onion, citrus juice, coffee, and tomatoes.

Obesity Diabetes Acid Reflux Anxiety And Low Iron Nutrition Plan Herbs (⭐️ Best Practices) | Obesity Diabetes Acid Reflux Anxiety And Low Iron Nutrition Plan What Is The Besthow to Obesity Diabetes Acid Reflux Anxiety And Low Iron Nutrition Plan for Potentially harmful medications that can aggravate the symptoms and effects of GERD in the elderly, such as NSAIDs, potassium tablets, bisphosphonates, beta blockers, theophylline and calcium-channel blockers should be avoided if possible. If these agents must be continued because of comorbid illness, the regimen should be modified on an individual basis, such as switching potassium tablets to an elixir or using an alternative medication or dosing frequency in the osteoporotic patient on biphosphonates. All medications should be given with 6-8 ounces of water in an upright position.

Over-the-counter antacids, histamine (H2) blockers and PPI agents on an as-needed basis may be helpful for those individuals who have mild disease. However, for the majority of patients, and certainly for those patients with complications, one must use prescription agents for more effective therapy[7].

Motility agents, such as cisapride, metoclopramide, erythromycin, bethanechol and the gamma-amino butyric acid B-receptor (GABA) agonist Baclofen have helped to improve LES tone and esophagogastric motility in selected patients[44]. However, their success is limited in patients with more severe disease. For patients with diabetes, cisapride and metoclopramide have been used with moderate success in improving gastric emptying and reducing GERD symptoms. However, cisapride is only available on a restricted-use basis due to potentially fatal cardiac arrhythmias. Metoclopramide must be used with caution in the elderly, because it can cause side effects, such as muscle tremors, spasms, agitation, insomnia, drowsiness, and tardive dyskinesia, in up to one-third of patients. Erythromycin use is limited by its side effects and tachyphylaxis. Bethanechol has not proved useful in GERD. Gamma-amino butyric acid B-receptor (GABA) agonists, such as Baclofen, reduce tLESRs and improve gastric emptying. However, side effects that are more common in the elderly, such as somnolence, confusion, dizziness, lightheadedness, weakness and trembling, limit their use in the older patient. Newer agents are under investigation[45].

Histamine H-2 receptor antagonists, including cimetidine, ranitidine, famotidine, and nizatidine, are helpful in patients with GERD, by providing good acid suppression and symptom relief. These drugs are remarkably similar in their action and equally effective at equivalent doses. However, high doses of up to four times daily may be necessary in some patients with severe symptoms. Reducing dosage because of renal insufficiency, which is more common in the elderly, is often necessary. In addition, all these agents, especially cimetidine, can cause delirium in the older patient. Drug-drug interactions with histamine H-2 receptor antagonists through metabolism of the hepatic cytochrome P-450 3A4 system may be potentially harmful in elderly patients who use medications such as warfarin, phenytoin, benzodiazepines, and theophylline. Side effects of these agents, especially cimetidine, are more common in the elderly and in those with comorbid illnesses. Side effects include central nervous system side effects, such as mental confusion, delirium, headache, and dizziness; antiandrogen side effects of gynecomastia and impotence; cardiac side effects of sinus bradycardia, atrioventricular block, and prolongation of the QT interval; and hematological side effects of anemia, neutropenia, and thrombocytopenia. However, most side effects are reversible with dosage reduction or withdrawal of the offending agent[7].

Proton pump inhibitors (PPIs), such as esomeprazole, lansoprazole, omeprazole, pantoprazole, rabeprazole, and dexlansoprazole are the most effective medical therapeutic agents for the treatment of GERD. Proton pump inhibitors provide excellent acid suppression and effective symptom relief[43]. These agents are particularly useful in elderly persons who often require more acid suppression due to more severe disease and complications. In older patients who are unable to swallow pills, capsules may be opened and the granules mixed in water or juice or sprinkled on applesauce or yogurt. For example, lansoprazole is available as an orally dissolving tablet and both lansoprazole and omeprazole powder are available as oral suspensions, which may be useful for those with swallowing disorders or those who require tube feedings.

Maintenance therapy is most often required, because relapses are common in elderly patients with GERD, especially those with associated complications. Long-term treatment with adequate doses of medication is the key to effective care in the elderly. For the majority of patients with esophageal strictures, the use of acid suppression and esophageal dilatation are effective. Aggressive acid suppression is effective in the majority of patients with GERD-related atypical chest pain. ENT complications, such as hoarseness, show dramatic response to these agents when adequate doses are used for prolonged periods. In patients with GERD-mediated asthma, significant improvement will occur with acid suppression by H2 blockers and PPIs. Maintenance therapy is required in all of these patients because relapses occur very soon after cessation of therapy. In patients with Barrett’s esophagus, chronic medical therapy is warranted, although its success remains controversial[45].

POTENTIAL EFFECTS OF PROLONGED ACID SUPPRESSION

Prolonged acid suppression by Histamine H-2 receptor antagonists and PPI agents may potentially affect nutrient and calcium absorption, bacterial proliferation, and drug metabolism in the older patient. However, with adequate monitoring, long term maintenance with PPI agents remains quite safe in the elderly population[46] (Table (Table33).

Obesity Diabetes Acid Reflux Anxiety And Low Iron Nutrition Plan Heartburn Relief (πŸ‘ GERD Diet) | Obesity Diabetes Acid Reflux Anxiety And Low Iron Nutrition Plan Treatmentshow to Obesity Diabetes Acid Reflux Anxiety And Low Iron Nutrition Plan for Table 3

Potential effects of prolonged acid suppression with histamine2 receptor antagonists and PPI agents

Reduced absorption of nutrients and calcium
B12, iron, calcium
Osteoporosis
Bacterial proliferation
Community acquired pneumonia
Clostridium difficile
Drug metabolism interference
Acid effects on drug absorption
PPI Effects on CYP2C19 pathway interference
Clopidogrel
Histamine2 receptor antagonists effects on cytochrome P-450 3A4 system
Warfarin, phenytoin, benzodiazepines, theophylline
Drug side effects
Delirium, especially cimetidine
Neurorologic
Antiandrogen
Cardiac side effects
Hematologic

PPI: proton pump inhibitor.

Vitamin B12, iron and calcium absorption can be affected. The effect on B12 and iron absorption appears to be insignificant, but periodic monitoring for anemia and reduced B12 and iron stores may be warranted[47].

Obesity Diabetes Acid Reflux Anxiety And Low Iron Nutrition Plan What Is The Best (πŸ”΄ 10 Remedies) | Obesity Diabetes Acid Reflux Anxiety And Low Iron Nutrition Plan Which Foods To Avoidhow to Obesity Diabetes Acid Reflux Anxiety And Low Iron Nutrition Plan for Reduction of calcium absorption and the potential development or worsening of osteoporosis and resultant bone fracture is a significant but controversial issue. Reduction in bone density and increased incidence of hip fractures has been reported with both PPI agents and Histamine H-2 receptor antagonists[48]. If these agents are used for maintenance therapy, patients should be monitored for osteoporosis as per recommended guidelines and given adequate intake of calcium and vitamin D. If osteoporosis is detected, treatment with appropriate agents, such as bisphosphanates should be offered. Withdrawal of acid suppression agents with worsening bone health in elderly patients must be considered.

Bacterial proliferation with an increased incidence of community acquired pneumonia and the development of gastrointestinal infection, such as Clostridium difficile associated colitis, has been reported and is important, although a controversial issue in the elderly patient. These patients have a higher incidence of comorbities and more often are in hospitals or long term care facilities. This would predispose them to frequent and more serious infections. Restriction of acid suppressant use in this regard remains controversial[49-50].

Interference of acid suppressant agents with drug metabolism is an issue. Acid inhibition may affect absorption of some drugs. Recently, interference with drug metabolism has become an issue with clopidogrel, which is often used for anticoagulation in the elderly. Omeprazole competitively interferes with conversion of clopidogrel to its active metabolite through the CYP2C19 pathway. The significance of this interference remains controversial, but switching to another PPI that may not significantly use this pathway, such as pantoprazole, lansoprazole or rabeprazole or switching to a Histamine H-2 receptor antagonist may be warranted[51].

Histamine H-2 receptor antagonists, especially cimetidine, can cause delirium in the older patient. Drug-drug interactions with histamine H-2 receptor antagonists through metabolism of the hepatic cytochrome P-450 3A4 system may be potentially harmful in elderly patients who use medications such as warfarin, phenytoin, benzodiazepines, and theophylline. Side effects of these agents, especially cimetidine, are more common in the elderly and in those with comorbid illnesses. Side effects include central nervous system side effects, such as mental confusion, delirium, headache, and dizziness; antiandrogen side effects of gynecomastia and impotency; cardiac side effects of sinus bradycardia, atrioventricular block, and prolongation of the QT interval; and hematological side effects of anemia, neutropenia, and thrombocytopenia. However, most side effects are reversible with dosage reduction or withdrawal of the offending agent[7].

Although the vast majority of elderly patients with complications associated with GERD can be successfully managed with medical therapy, invasive methods of surgery and endoscopic treatment may be warranted in some cases. Surgery is an option for some patients with GERD[52] and is now more frequently considered because of the ability to perform antireflux surgery laparoscopically. It is indicated in patients with intractable GERD, difficult-to-manage strictures, severe bleeding, nonhealing ulcers, recurrent aspiration, and GERD requiring large maintenance doses of PPI agents or H-2 receptor antagonists. Barrett’s esophagus alone is not an indication for surgery. However, surgery is warranted for high grade dysplasia and esophageal adenocarcinoma. Given that there appears to be no greater increase in postoperative morbidity or mortality in the elderly with this type of surgery, healthy elderly patients should not be denied surgery on the basis of age alone[53]. Careful patient selection with complete preoperative evaluation, including upper GI endoscopy, esophageal manometry, pH testing, and gastric emptying studies, should be done prior to surgery.

Endoscopic therapy of GERD has had little success. Implantation of a biocompatible, non-biodegradable polymer (Enteryx) into the gastric cardia and radiofrequency energy delivery to the gastroesophageal junction, the Stretta Procedure, are available for the treatment of GERD on an investigational basis only[54-55]. Endoscopic suturing below the gastroesophageal junction is possible and has been used with some success to treat GERD[56]. However, further investigation and perfection of this technique is warranted. Pyloric injections of botulinum toxin in patients with refractory GERD and gastroparesis has had limited short term success. Endoscopic ablative techniques for treatment of Barrett’s esophagus are evolving. They include endoscopic mucosal resection, electrocautery fulguration, laser photoablation and photodynamic therapy. Implantable gastric electrodes and botulinum injection of the pylorus to improve gastric emptying are further techniques being evaluated to reduce gastroesophageal reflux. Additional evaluation of these therapeutic techniques is warranted[57] (Table (Table4 the 1 last update 01 Jun 2020 44).

Table 4

Invasive treatment of gastroesophageal reflux disease endoscopic therapy

Evolving techniques
Non-biodegradable polymer
Radiofrequency treatment of the gastroesophageal junction
Endoscopic suturing
Implantable gastric electrodes
Botulinum injection of the pyloris
Ablative techniques for Barrett’s esophagus
Endoscopic mucosal resection
Electrocautery fulguration
Laser photoablation
Photodynamic therapy
Surgery
Laparoscopic fundoplication

CONCLUSION

GERD and its associated complications are common in the older patient. The elderly tend to have fewer symptoms with more severe complications that may be life threatening. There are important considerations regarding causation, evaluation and treatment in the older as compared to the younger patient. However, with appropriate management, GERD and its associated complications can be treated successfully in majority of elderly patients.

Footnotes

Obesity Diabetes Acid Reflux Anxiety And Low Iron Nutrition Plan Natural Remedies For (β˜‘ Treatments) | Obesity Diabetes Acid Reflux Anxiety And Low Iron Nutrition Plan Heartburn Naturallyhow to Obesity Diabetes Acid Reflux Anxiety And Low Iron Nutrition Plan for

Obesity Diabetes Acid Reflux Anxiety And Low Iron Nutrition Plan Naturally Treat (πŸ‘ Home Remedies For) | Obesity Diabetes Acid Reflux Anxiety And Low Iron Nutrition Plan Heartburn Remedieshow to Obesity Diabetes Acid Reflux Anxiety And Low Iron Nutrition Plan for Peer reviewers: Shinji Nishiwaki, MD, PhD, Director, Department of Internal Medicine, Nishimino Kosei Hospital, Yoro-cho, Yoro-gun, Gifu 503-1394, Japan; Kaushal Kishor Prasad, MD, PDCC, Associate Professor, Chief, Division of GE Histopathology, Department of Superspeciality for Gastroenterology, Postgraduate Institute of Medical Education and Research, Sector-12, Chandigarh, UT 160012, India

Obesity Diabetes Acid Reflux Anxiety And Low Iron Nutrition Plan 7 Foods That Cause (πŸ‘ Treat GERD) | Obesity Diabetes Acid Reflux Anxiety And Low Iron Nutrition Plan Diet Changes Forhow to Obesity Diabetes Acid Reflux Anxiety And Low Iron Nutrition Plan for for 1 last update 01 Jun 2020

Obesity Diabetes Acid Reflux Anxiety And Low Iron Nutrition Plan Diet For (πŸ”΄ Foods To Avoid) | Obesity Diabetes Acid Reflux Anxiety And Low Iron Nutrition Plan Naturally Treathow to Obesity Diabetes Acid Reflux Anxiety And Low Iron Nutrition Plan for S- Editor Zhang HN L- Editor Hughes D E- Editor Liu N

References

1. Shaheen NJ, Hansen RA, Morgan DR, Gangarosa LM, Ringel Y, Thiny MT, Russo MW, Sandler RS. The burden of gastrointestinal and liver diseases, 2006. Am J Gastroenterol. 2006;101:2128–2138. [PubMed] [Google for 1 last update 01 Jun 2020 Scholar][Google Scholar]
2. Fujiwara Y, Higuchi K, Watanabe Y, Shiba M, Watanabe T, Tominaga K, Oshitani N, Matsumoto T, Nishikawa H, Arakawa T. Prevalence of gastroesophageal reflux disease and gastroesophageal reflux disease symptoms in Japan. J Gastroenterol Hepatol. 2005;20:26–29. [PubMed] [Google Scholar]
3. Wong WM, Lai KC, Lam KF, Hui WM, Hu WH, Lam CL, Xia HH, Huang JQ, Chan CK, Lam SK, et al. Prevalence, clinical spectrum and health care utilization of gastro-oesophageal reflux disease in a Chinese population: a population-based study. Aliment Pharmacol Ther. 2003;18:595–604.Aliment Pharmacol Ther. 2003;18:595–604. [PubMed] [Google for 1 last update 01 Jun 2020 Scholar][Google Scholar]
4. Obesity Diabetes Acid Reflux Anxiety And Low Iron Nutrition Plan List Of (πŸ”΄ Foods To Eat And Avoid) | Obesity Diabetes Acid Reflux Anxiety And Low Iron Nutrition Plan Heartburn During Pregnancyhow to Obesity Diabetes Acid Reflux Anxiety And Low Iron Nutrition Plan for El-Serag HB. Time trends of gastroesophageal reflux disease: a systematic review. Clin Gastroenterol Hepatol. 2007;5:17–26. [PubMed] [Google Scholar]
5. Sandler RS, Everhart JE, Donowitz M, Adams E, Cronin K, Goodman C, Gemmen E, Shah S, Avdic A, Rubin R. The burden of selected digestive diseases in the United States. Obesity Diabetes Acid Reflux Anxiety And Low Iron Nutrition Plan Side Effects (πŸ‘ Acid Reflux) | Obesity Diabetes Acid Reflux Anxiety And Low Iron Nutrition Plan 9 Natural Remedieshow to Obesity Diabetes Acid Reflux Anxiety And Low Iron Nutrition Plan for Gastroenterology. 2002;122:1500–1511. [PubMed] [Google Scholar]
6. Obesity Diabetes Acid Reflux Anxiety And Low Iron Nutrition Plan Naturally Treat (⭐️ 12 Tips) | Obesity Diabetes Acid Reflux Anxiety And Low Iron Nutrition Plan What Is The Besthow to Obesity Diabetes Acid Reflux Anxiety And Low Iron Nutrition Plan for Johnson DA, Fennerty MB. Heartburn severity underestimates erosive esophagitis severity in elderly patients with gastroesophageal reflux disease. Gastroenterology. 2004;126:660–664. [PubMed] [Google Scholar]Johnson DA, Fennerty MB. Heartburn severity underestimates erosive esophagitis severity in elderly patients with gastroesophageal reflux disease. Gastroenterology. 2004;126:660–664. [PubMed] [Google Scholar]
7. Chait MM. Complications of gastroesophageal reflux disease in the elderly. Annals of for 1 last update 01 Jun 2020 Long Term Care. 2005;13:8–32. [Google Scholar]Chait MM. Complications of gastroesophageal reflux disease in the elderly. Annals of Long Term Care. 2005;13:8–32. [Google Scholar]
8. Robertson D, Aldersley M, Shepherd H, Smith CL. Patterns of acid reflux in complicated oesophagitis. Gut. 1987;28:1484–1488. [PMC free article] [PubMed] Obesity Diabetes Acid Reflux Anxiety And Low Iron Nutrition Plan Diet (β˜‘ Treatment) | Obesity Diabetes Acid Reflux Anxiety And Low Iron Nutrition Plan Instant Heartburn Reliefhow to Obesity Diabetes Acid Reflux Anxiety And Low Iron Nutrition Plan for [Google Scholar]
9. Lagergren J, Bergström R, Lindgren A, Nyrén O. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. Obesity Diabetes Acid Reflux Anxiety And Low Iron Nutrition Plan Diet Changes For (πŸ”΄ Best Practices) | Obesity Diabetes Acid Reflux Anxiety And Low Iron Nutrition Plan 7 Foods That Causehow to Obesity Diabetes Acid Reflux Anxiety And Low Iron Nutrition Plan for N Engl J Med. 1999;340:825–831. [PubMed] [Google Scholar]
10. Labenz J, Jaspersen D, Kulig M, Leodolter A, Lind T, Meyer-Sabellek W, Stolte M, Vieth M, Willich S, Malfertheiner P. Risk factors for erosive esophagitis: a multivariate analysis based on the ProGERD study initiative. Am J Gastroenterol. 2004;Obesity Diabetes Acid Reflux Anxiety And Low Iron Nutrition Plan Symptoms (β˜‘ Soothe The Pain) | Obesity Diabetes Acid Reflux Anxiety And Low Iron Nutrition Plan 12 Tipshow to Obesity Diabetes Acid Reflux Anxiety And Low Iron Nutrition Plan for 99:1652–1656. [PubMed] [Google Scholar]
11. Chait MM. The association and clinical implications of gastroesophageal reflux disease and H pylori. Obesity Diabetes Acid Reflux Anxiety And Low Iron Nutrition Plan To Avoid (⭐️ The Discomfort) | Obesity Diabetes Acid Reflux Anxiety And Low Iron Nutrition Plan Testshow to Obesity Diabetes Acid Reflux Anxiety And Low Iron Nutrition Plan for Practical Gastroenterology. 2006;30:40–48. [Google Scholar]
12. Farup C, Kleinman L, Sloan S, Ganoczy D, Chee E, Lee C, Revicki D. The impact of nocturnal symptoms associated with gastroesophageal reflux disease on health-related quality of life. Arch Intern Med. 2001;161:45–52. [PubMed] [Google for 1 last update 01 Jun 2020 Scholar][Google Scholar]
13. Shaker R, Castell DO, Schoenfeld PS, Spechler SJ. Nighttime heartburn is an under-appreciated clinical problem that impacts sleep and daytime function: the results of a Gallup survey conducted on behalf of the American Gastroenterological Association. Am J Gatroenterol. 2003;98:1487–1493. [PubMed] [Google Scholar][Google Scholar]
14. American Gastroenterological Association (AGA) The burden of gastrointestinal disease. Bethesda, Md: AGA; 2001. [Google Scholar]
15. Obesity Diabetes Acid Reflux Anxiety And Low Iron Nutrition Plan Causes (πŸ‘ Acid Reflux Symptoms) | Obesity Diabetes Acid Reflux Anxiety And Low Iron Nutrition Plan Simples Steps Tohow to Obesity Diabetes Acid Reflux Anxiety And Low Iron Nutrition Plan for Brook RA, Wahlqvist P, Kleinman NL, Wallender MA, Campbell SM, Smeeding JE. Cost of gastroesophageal reflux disease to the employer: a perspective from the United States. Alim the 1 last update 01 Jun 2020 Pharmacol Ther. 2007;26:889–898.Alim Pharmacol Ther. 2007;26:889–898. [PubMed] [Google Scholar]
16. Collen MJ, Abdulian JD, Chen YK. Gastroesophageal reflux disease in the elderly: more severe disease that requires aggressive therapy. Am J Gastroenterol. 1995; the 1 last update 01 Jun 2020 9090:1053–1057. [PubMed] [Google Scholar]
17. Huang X, Zhu HM, Deng CZ, Porro GB, Sangaletti O, Pace F. Gastroesophageal reflux: the features in elderly patients. World J Gastroenterol. 1999;5:421–423. [PMC free the 1 last update 01 Jun 2020 article][PMC free article] [PubMed] [Google Scholar]
18. DeVault KR, Castell DO. Updated guidelines for the diagnosis and treatment of gastroesophageal reflux disease. Am J Gastroenterol. 2005;100:190–200. [PubMed] [Google Scholar]
19. Vakil N, van Zanten SV, Kahrilas P, Dent J, Jones R. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol. 2006;101:1900–1920; quiz 1943. [PubMed] [Google Scholar]
20. Ferriolli E, Oliveira RB, Matsuda NM, Braga FJ, Dantas RO. Aging, esophageal motility, and gastroesophageal reflux. J Am Geriatr Soc. 1998;46:1534–1547. [PubMed] [Google Scholar]
21. Fass R, Pulliam G, Johnson C, Garewal HS, Sampliner RE. Symptom severity and oesophageal chemosensitivity to acid in older and young patients with gastro-oesophageal reflux. Obesity Diabetes Acid Reflux Anxiety And Low Iron Nutrition Plan How To Get Rid (⭐️ Heartburn Medicine) | Obesity Diabetes Acid Reflux Anxiety And Low Iron Nutrition Plan Cause Acid Refluxhow to Obesity Diabetes Acid Reflux Anxiety And Low Iron Nutrition Plan for Age Ageing. 2000; the 1 last update 01 Jun 2020 2929:125–130. [PubMed] [Google Scholar]
22. Sonnenberg A, Steinkamp U, Weise A, Berges W, Wienbeck M, Rohner HG, Peter P. Salivary secretion in reflux esophagitis. Gastroenterology. 1982;83:889–895. [PubMed] [Google Scholar]
23. Hurwitz A, Brady DA, Schaal SE, Samloff IM, Dedon J, Ruhl CE. Gastric acidity in older adults. JAMA. 1997;278:659–662. [PubMed] [Google Scholar]
24. Jacobson BC, Somers SC, Fuchs CS, Kelly CP, Camargo CA Jr. Body-mass index and symptoms of gastroesophageal reflux in women. N Engl J Med. 2006;354:2340–2348. [PMC free article] [PubMed] [Google Scholar]
25. Orr WC. Reflux events and sleep: are we vulnerable? Curr Gastroenterol Rep. 2006;Obesity Diabetes Acid Reflux Anxiety And Low Iron Nutrition Plan Diet (πŸ”₯ Natural Remedies) | Obesity Diabetes Acid Reflux Anxiety And Low Iron Nutrition Plan Diet Changes Forhow to Obesity Diabetes Acid Reflux Anxiety And Low Iron Nutrition Plan for 8:202–207. [PubMed] [Google Scholar]
26. Mody R, Bolge SC, Kannan H, Fass R. Effects of gastroesophageal reflux disease on sleep and outcomes. Obesity Diabetes Acid Reflux Anxiety And Low Iron Nutrition Plan 7 Foods That Cause (β˜‘ Naturally Treat) | Obesity Diabetes Acid Reflux Anxiety And Low Iron Nutrition Plan 7 Home Remedieshow to Obesity Diabetes Acid Reflux Anxiety And Low Iron Nutrition Plan for Clin Gastroenterol Hepatol. 2009;7:953–959. [PubMed] [Google Scholar]
27. Sharma P. Recent advances in Barrett’s esophagus: short-segment Barrett’s esophagus and cardia intestinal metaplasia. Semin Gastrointest Dis. 1999;10:93–102. [PubMed] [Google Scholar]
28. Zhang J, Chen XL, Wang KM, Guo XD, Zuo AL, Gong J. Relationship of gastric Helicobacter pylori infection to Barrett’s esophagus and gastro-esophageal for 1 last update 01 Jun 2020 reflux disease in Chinese. World J the 1 last update 01 Jun 2020 Gastroenterol. 2004;10:672–675.World J Gastroenterol. 2004;10:672–675. [PMC free article] [PubMed] [Google Scholar][Google Scholar]Zhang J, Chen XL, Wang KM, Guo XD, Zuo AL, Gong J. Relationship of gastric Helicobacter pylori infection to Barrett’s esophagus and gastro-esophageal reflux disease in Chinese. World J the 1 last update 01 Jun 2020 Gastroenterol. 2004;10:672–675.World J Gastroenterol. 2004;10:672–675. [PMC free article] [PubMed] [Google Scholar][Google Scholar]
29. Ye W, Held M, Lagergren J, Engstrand L, Blot WJ, McLaughlin JK, Nyrén O. Helicobacter pylori infection and gastric atrophy: risk of adenocarcinoma and squamous-cell carcinoma of the esophagus and adenocarcinoma of the gastric cardia. J Natl Cancer Inst. 2004;96:388–396. [PubMed] [Google Scholar]
30. Obesity Diabetes Acid Reflux Anxiety And Low Iron Nutrition Plan Heartburn Remedies (⭐️ 13 Surprising) | Obesity Diabetes Acid Reflux Anxiety And Low Iron Nutrition Plan To Eathow to Obesity Diabetes Acid Reflux Anxiety And Low Iron Nutrition Plan for Traube M. The spectrum of the symptoms and presentations of gastroesophageal reflux disease. Obesity Diabetes Acid Reflux Anxiety And Low Iron Nutrition Plan How To Get Rid (πŸ”₯ Diagnosis) | Obesity Diabetes Acid Reflux Anxiety And Low Iron Nutrition Plan GERDhow to Obesity Diabetes Acid Reflux Anxiety And Low Iron Nutrition Plan for Gastroenterol Clin North Am. 1990;19:609–616. [PubMed] [Google Scholar]
31. Räihä IJ, Impivaara O, Seppälä M, Sourander LB. Prevalence and characteristics of symptomatic gastroesophageal reflux disease in the elderly. J Am Geriatr Soc. 1992;40:1209–1211. [PubMed] [Google Scholar]
32. Chait MM, Saffel D. Gastroesophageal reflux disease in the elderly. Pharmacy Times. Bethesda, Md: AGA; 2006. pp. 101–107. [Google Scholar]
33. Richter JE. Gastroesophageal reflux disease in the the 1 last update 01 Jun 2020 older patient: presentation, treatment, and complications. Am J Gastroenterol. 2000;95:368–373. [PubMed] [Google Scholar]Richter JE. Gastroesophageal reflux disease in the older patient: presentation, treatment, and complications. Am J Gastroenterol. 2000;95:368–373. [PubMed] [Google Scholar]
34. Spechler SJ. Barrett’s esophagus. Obesity Diabetes Acid Reflux Anxiety And Low Iron Nutrition Plan Natural Remedies (πŸ”₯ Treatment) | Obesity Diabetes Acid Reflux Anxiety And Low Iron Nutrition Plan 9 Natural Remedieshow to Obesity Diabetes Acid Reflux Anxiety And Low Iron Nutrition Plan for Semin the 1 last update 01 Jun 2020 Oncol. Semin Oncol. 1994;21:431. [PubMed] Obesity Diabetes Acid Reflux Anxiety And Low Iron Nutrition Plan Symptoms (πŸ”΄ Reflux Disease) | Obesity Diabetes Acid Reflux Anxiety And Low Iron Nutrition Plan Acid Refluxhow to Obesity Diabetes Acid Reflux Anxiety And Low Iron Nutrition Plan for [Google Scholar][Google Scholar]
35. van der Burgh A, Dees J, Hop WC, van Blankenstein M. Oesophageal cancer is an uncommon cause of death in patients with Barrett’s oesophagus. Obesity Diabetes Acid Reflux Anxiety And Low Iron Nutrition Plan Acid Reflux (β˜‘ Quick Relief) | Obesity Diabetes Acid Reflux Anxiety And Low Iron Nutrition Plan 10 Home Remedieshow to Obesity Diabetes Acid Reflux Anxiety And Low Iron Nutrition Plan for Gut. 1996;39:5–8. [PMC free article] [PubMed] [Google Scholar][Google Scholar]
36. Ruigómez A, García Rodríguez LA, Wallander MA, Johansson S, Graffner H, Dent J. Natural history of gastro-oesophageal reflux disease diagnosed in general practice. Aliment Pharmacol Ther. 2004;20:751–760. [PubMed] [Google Scholar]
37. Wong RK, Hanson DG, Waring PJ, Shaw G. ENT manifestations of gastroesophageal reflux. Obesity Diabetes Acid Reflux Anxiety And Low Iron Nutrition Plan Heartburn Remedies (πŸ”΄ 9 Natural Remedies) | Obesity Diabetes Acid Reflux Anxiety And Low Iron Nutrition Plan What To Eathow to Obesity Diabetes Acid Reflux Anxiety And Low Iron Nutrition Plan for Am J Gastroenterol. 2000;95:S15–S22. [PubMed] [Google Scholar]
38. Irwin RS, French CL, Curley FJ, Zawacki JK, Bennett FM. Chronic cough due to gastroesophageal reflux. Clinical, diagnostic, and pathogenetic aspects. 1993. Chest. 2009;136:e30. [PubMed] [Google Scholar]
39. Wong WM, Wong BC. Definition and diagnosis of gastroesophageal reflux disease. J Gastroenterol Hepatol. 2004;19 Suppl 3:S26–S32. [PubMed] [Google Scholar]
40. Pandolfino JE, Bianchi LK, Lee TJ, Hirano I, Kahrilas PJ. Esophagogastric junction morphology predicts susceptibility to exercise-induced reflux. Am J Gastroenterol. 2004; the 1 last update 01 Jun 2020 9999:1430–1466. [PubMed] [Google Scholar]
41. Hong SK, Vaezi MF. Gastroesophageal reflux monitoring: pH (catheter and capsule) and impedance. Gastrointest Endosc Clin N Am. 2009;19:1–22. [PubMed] [Google the 1 last update 01 Jun 2020 Scholar][Google Scholar]
42. Fennerty MB. Use of a the 1 last update 01 Jun 2020 therapeutic trial as a diagnostic test for GERD. Practical Gastroenterology. 2004;28:45–50. [Google Scholar]Fennerty MB. Use of a therapeutic trial as a diagnostic test for GERD. Practical Gastroenterology. 2004;28:45–50. [Google Scholar]
43. Kahrilas PJ. Clinical practice. Gastroesophageal reflux disease. Obesity Diabetes Acid Reflux Anxiety And Low Iron Nutrition Plan Breakfast For (πŸ‘ Heartburn Relief) | Obesity Diabetes Acid Reflux Anxiety And Low Iron Nutrition Plan Solutionshow to Obesity Diabetes Acid Reflux Anxiety And Low Iron Nutrition Plan for N Engl J Med. 2008;359:1700–1707. [PMC free article] [PubMed] [Google Scholar]
44. Chait MM. Lower gastrointestinal bleeding in the elderly. World J Gastrointest Endosc. 2010;2:147–154. [PMC free article] [PubMed] [Google Scholar]
45. Boeckxstaens GE, Beaumont H, Mertens V, Denison H, Ruth M, Adler J, Silberg DG, Sifrim D. Effects of lesogaberan on reflux and lower esophageal sphincter function in patients with gastroesophageal reflux disease. Gastroenterology. 2010;139:409–417. [PubMed] [Google Scholar]
46. Laine L, Ahnen D, McClain C, Solcia E, Walsh JH. Review article: potential gastrointestinal effects of long-term acid suppression with proton pump inhibitors. Obesity Diabetes Acid Reflux Anxiety And Low Iron Nutrition Plan Other Natural Remedies (πŸ‘ Acid Reflux Symptoms) | Obesity Diabetes Acid Reflux Anxiety And Low Iron Nutrition Plan 23+ Home Remedieshow to Obesity Diabetes Acid Reflux Anxiety And Low Iron Nutrition Plan for Aliment Pharmacol Ther. 2000;14:651–668. [PubMed] [Google Scholar][Google Scholar]
47. McColl KEI. Effect of proton pump inhibitors on vitamins and iron. Am J Gastroenterol. 2009;104:S5–S9. [PubMed] [Google Scholar]
48. Laine L. Proton pump inhibitors the 1 last update 01 Jun 2020 and bone fractures? Am J Gastroenterol. 2009;104:S21–S26. [PubMed] [Google Scholar]Laine L. Proton pump inhibitors and bone fractures? Am J Gastroenterol. 2009;104:S21–S26. [PubMed] [Google Scholar]
49. Dial MS. Proton pump inhibitor use and enteric infections. Obesity Diabetes Acid Reflux Anxiety And Low Iron Nutrition Plan The Discomfort (πŸ”΄ Remedy Relief) | Obesity Diabetes Acid Reflux Anxiety And Low Iron Nutrition Plan 7 Natural GERDhow to Obesity Diabetes Acid Reflux Anxiety And Low Iron Nutrition Plan for Am J for 1 last update 01 Jun 2020 Gastroenterol. 2009;104:S17–S20.Am J Gastroenterol. 2009;104:S17–S20. [PubMed] [Google Scholar]
50. Vakil N. Acid inhibition and infections outside the gastrointestinal tract. Obesity Diabetes Acid Reflux Anxiety And Low Iron Nutrition Plan Home Remedies For (πŸ‘ Diet For) | Obesity Diabetes Acid Reflux Anxiety And Low Iron Nutrition Plan Disease Treatmenthow to Obesity Diabetes Acid Reflux Anxiety And Low Iron Nutrition Plan for Am J Gastroenterol. 2009; the 1 last update 01 Jun 2020 104104:S10–S16. [Google Scholar]
51. Ray WA, Murray KT, Griffin MR, Chung CP, Smalley WE, Hall K, Daugherty JR, Kaltenbach LA, Stein CM. Outcomes with concurrent use of clopidogrel and proton-pump inhibitors: a cohort study. Ann Intern Med. 2010;152:337–345. [PMC free article] [PubMed] Obesity Diabetes Acid Reflux Anxiety And Low Iron Nutrition Plan 10 Foods To Eat (β˜‘ 7 Home Remedies) | Obesity Diabetes Acid Reflux Anxiety And Low Iron Nutrition Plan How To Get Ridhow to Obesity Diabetes Acid Reflux Anxiety And Low Iron Nutrition Plan for [Google Scholar]
52. Spechler SJ. Comparison of medical and surgical therapy for complicated gastroesophageal reflux disease in veterans. The Department of Veterans Affairs Gastroesophageal Reflux Disease Study Group. Obesity Diabetes Acid Reflux Anxiety And Low Iron Nutrition Plan Stops Acid Reflux (β˜‘ How To) | Obesity Diabetes Acid Reflux Anxiety And Low Iron Nutrition Plan Heartburnhow to Obesity Diabetes Acid Reflux Anxiety And Low Iron Nutrition Plan for N Engl the 1 last update 01 Jun 2020 J Med. N Engl J Med. 1992;326:786–792. [PubMed] [Google Scholar]
53. Trus TL, Laycock WS, Wo JM, Waring JP, Branum GD, Mauren SJ, Katz EM, Hunter JG. Laparoscopic antireflux surgery in the elderly. Obesity Diabetes Acid Reflux Anxiety And Low Iron Nutrition Plan Best Home Remedies (⭐️ Home Remedies) | Obesity Diabetes Acid Reflux Anxiety And Low Iron Nutrition Plan Foods That Can Helphow to Obesity Diabetes Acid Reflux Anxiety And Low Iron Nutrition Plan for Am J Gastroenterol. 1998;93:351–353. [PubMed] [Google Scholar]
54. Johnson DA, Ganz R, Aisenberg J, Cohen LB, Deviere J, Foley TR, Haber GB, Peters JH, Lehman GA. Endoscopic, deep mural implantation of Enteryx for the treatment of GERD: 6-month follow-up of a multicenter trial. Am for 1 last update 01 Jun 2020 J Gastroenterol. Am J Gastroenterol. 2003;98:250–258. [PubMed] [Google for 1 last update 01 Jun 2020 Scholar][Google Scholar]
55. Triadafilopoulos G, DiBaise JK, Nostrant TT, Stollman NH, Anderson PK, Wolfe MM, Rothstein RI, Wo JM, Corley DA, Patti MG, et al. The Stretta procedure for the treatment of GERD: 6 and 12 month follow-up of the U.S. open label trial. Gastrointest Endosc. 2002;55:149–156. [PubMed] [Google Scholar]
56. Mahmood Z, McMahon BP, Arfin Q, Byrne PJ, Reynolds JV, Murphy EM, Weir DG. Endocinch therapy for 1 last update 01 Jun 2020 for gastro-oesophageal reflux disease: a one year prospective follow up. Gut. 2003;52:34–39. [PMC free article] [PubMed] [Google Scholar]Mahmood Z, McMahon BP, Arfin Q, Byrne PJ, Reynolds JV, Murphy EM, Weir DG. Endocinch therapy for gastro-oesophageal reflux disease: a one year prospective follow up. Gut. 2003;52:34–39. [PMC free article] [PubMed] [Google Scholar]
57. Dellon ES, Shaheen NJ. Persistent reflux symptoms in the proton pump era: the changing face of gastroesophageal reflux disease. Gastroenterology. 2010;139:7–13. [PubMed] [Google Scholar]

Articles from World Journal of Gastrointestinal Endoscopy are provided here courtesy of Baishideng Publishing Group Inc
External link. Please review our privacy policy.

National Center for Biotechnology Information, U.S. National Library of Medicine 8600 Rockville Pike, Bethesda MD, 20894 Obesity Diabetes Acid Reflux Anxiety And Low Iron Nutrition Plan Acidity (πŸ”₯ 7 Home Remedies) | Obesity Diabetes Acid Reflux Anxiety And Low Iron Nutrition Plan List Ofhow to Obesity Diabetes Acid Reflux Anxiety And Low Iron Nutrition Plan for USA

Policies and Guidelines | Contact